Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| TRAVERE THERAPEUTICS | 16 | 11 | +2,29 % | ||
| PRAXIS PRECISION MEDICINES | 11 | - | 0,00 % | ||
| BIONTECH | 8 | 13 | 0,00 % | ||
| REVOLUTION MEDICINES | 8 | 5 | +1,97 % | ||
| BEONE MEDICINES LTD ADR | 5 | 10 | +0,76 % | ||
| ALLOGENE THERAPEUTICS | 5 | 6 | 0,00 % | ||
| LIGAND PHARMACEUTICALS | 5 | 2 | 0,00 % | ||
| PROTAGONIST THERAPEUTICS | 4 | 3 | -1,69 % | ||
| MEIRAGTX | 4 | - | -2,60 % | ||
| SANA BIOTECHNOLOGY | 4 | - | 0,00 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08:05 | Why are Mesoblast shares jumping 8% today? | - | The Motley Fool Australia | ||
| 07:59 | Mesoblast Secures Exclusive CAR-MSC Technology License; Stock Up | - | RTTNews | ||
| 07:59 | Revolution Medicines Prices $2 Bln Upsized Offering At $142/shr | - | RTTNews | ||
| 07:06 | Revolution Medicines prices $2 billion in stock and debt offerings | 2 | Investing.com | ||
| 06:58 | Revolution Medicines sichert sich 2 Milliarden US-Dollar durch Aktienplatzierung und Wandelanleihen | 2 | Investing.com Deutsch | ||
| 06:48 | Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes | 2 | GlobeNewswire (USA) | ||
| 06:36 | Spyre Therapeutics prices upsized $403M stock deal; gross proceeds exceed initial $300M goal | 1 | Seeking Alpha | ||
| 06:35 | Why Evolution Mining, Mesoblast, Nufarm, and Virgin Australia shares are storming higher today | 1 | The Motley Fool Australia | ||
| 06:30 | Mesoblast: Wenn aus Vision plötzlich Umsatz wird | Small- & Micro Cap Investment | |||
| 05:06 | Spyre Therapeutics prices $403M public stock offering at $62 | 1 | Investing.com | ||
| 04:42 | Spyre Therapeutics, Inc.: Spyre Therapeutics Announces Pricing of Upsized $403.0 Million Public Offering of Common Stock | 2 | GlobeNewswire (USA) | ||
| 04:18 | Allogene prices $175 million stock offering at $2 per share | 2 | Investing.com | ||
| 03:54 | Allogene Therapeutics, Inc.: Allogene Therapeutics Announces Pricing of Public Offering of Common Stock | 1 | GlobeNewswire (USA) | ||
| 02:30 | Mesoblast acquires CAR technology license from Mayo Clinic | 1 | Investing.com | ||
| 02:12 | Mesoblast Limited: Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products | 1 | GlobeNewswire (USA) | ||
| 00:46 | Bouncing Back From Trial Failure, Travere Wins First FDA Approval in Rare Kidney Disease | 1 | MedCity News | ||
| 00:25 | MESOBLAST LIMITED: Acquires CAR Platform for Precision-Enhanced Cell Products | - | ASX | ||
| Di | Praxis Precision Medicines: FDA akzeptiert Zulassungsantrag für Tremor-Medikament - Aktie im Aufwind | 1 | Investing.com Deutsch | ||
| Di | BeiGene Q1 2026 Earnings Preview | 2 | Seeking Alpha | ||
| Di | FDA Approves Travere's Filspari for Treatment of Focal Segmental Glomerulosclerosis | 1 | Contract Pharma |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.